circRNA basic information
circBase ID: hsa_circ_0007990
Name: hsa_circ_PGAP3
Synonym: circPGAP3
Host Gene: PGAP3
Genomic location(hg19): chr17:37840849-37842272:-
Genomic location(hg38): chr17:39684596-39686019:-
Subcellular localization: nucleus
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0007254
MONDO name: breast cancer
Disease details: breast cancer / BC
Disease DO ID:
1612
Disease MeSH ID:
-
Disease NCIt ID:
C9335
Disease ICD11 ID:
1047754165
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

BC tissues; adjacent non-tumor tissues; xenograft tumors

Cell lines:

MCF-10A; MCF-7; MDA-MB-231; T47D; BT549; MDA-MB-468

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: YBX1, E2F1
Associated microRNA: -
Biological function: promotes breast cancer cell growth/proliferation and tumorigenesis
Molecular mechanism: binds YBX1 and inhibits ubiquitin/proteasome-dependent degradation of YBX1, thereby increasing YBX1-dependent E2F1 transcription
Biological pathway or process:

proliferation (promotes); cell cycle (promotes); ubiquitination (inhibits)

Detected method:
Q
H
S
Validation methods:

circRNA-seq; Bioinformatics Analysis; RT-qPCR; ISH (In Situ Hybridization); Back-Splice Junction PCR / divergent primers PCR; Sanger Sequencing; RNase R Treatment; Nuclear-Cytoplasmic Fractionation; FISH / smFISH; RNA Pull-Down; RIP (RNA Immunoprecipitation); IF (Immunofluorescence); Transfection; CCK8; Colony Formation Assay; EdU Staining; Cell Cycle Assay; In Vivo Animal Model; H&E Staining; IHC (Immunohistochemistry); Luciferase Reporter Assay; ChIP / ChIP-seq; Western Blot; Co-IP

Clinical significance:

Higher expression in BC tissues and associated with malignant progression features (larger tumours, lymph node metastasis, high Ki67, ER- subgroup); correlation with YBX1 protein and E2F1 mRNA in BC tissues

Description:

In breast cancer, hsa_circ_0007990 (circPGAP3) is up-regulated in tissues and cell lines and promotes tumor cell growth in vitro and in vivo. It predominantly localizes to the nucleus, binds YBX1, inhibits ubiquitin/proteasome-dependent degradation of YBX1, and thereby increases YBX1-dependent E2F1 transcription to drive proliferation/cell-cycle progression.

Confidence score:

0.8647

Other information
Title:

Hsa_circ_0007990 promotes breast cancer growth via inhibiting YBX1 protein degradation to activate E2F1 transcription.

Journal: Cell death & disease
Published: 2024
PubMed ID: 38378679
Study type:

combined biological and clinical study

Data availability: The data sets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Code availability: -